Document:

Exhibit
10.1

 

SUBSCRIPTION
AGREEMENT

 

Bone
Biologics Corporation

2
Burlington Woods Dr., Suite 100

Burlington,
MA 101803

 

Gentlemen:

 

The
undersigned subscriber or subscribers (hereinafter, the “Purchaser”) has received and carefully read
this subscription agreement (the “Agreement”) and the Confidential Offering Documents for Accredited
Investors as may be amended or supplemented from time to time consisting of certain of the Company’s securities filings
(the “Securities Filings”) which have been filed with the Securities and Exchange Commission (“SEC”)
which are available at www.sec.gov (the “Offering Documents”) which relates to the offering of securities
(the “Offering”) of Bone Biologics Corporation, a Delaware corporation (the “Company”).

 

1.
Subscription. Subject to the terms and conditions of this Agreement, the Purchaser hereby irrevocably subscribes
for and agrees to purchase the number of Shares (the “Shares”) of the Company, on the signature page
hereof at a purchase price of $2.00 per Share (the “Share Purchase Price”) and hereby tenders this Agreement,
together with a check or wire transfer in such amount to the Company for such purchase.

 

The
Purchaser agrees that this subscription shall be irrevocable and shall survive the death or disability of the Purchaser. The Purchaser
understands that if this subscription is not accepted, in whole or in part, funds received by the Company pursuant hereto will
be returned to the Purchaser, without interest accrued thereon or deduction therefrom.

 

2.
Acceptance of Subscription. The Purchaser acknowledges that the Company has the right (in its sole discretion) to
accept or reject this subscription, in whole or in part, for any reason, and that this subscription shall be deemed to be accepted
by the Company only when it is signed on its behalf. The Agreement either will be accepted or rejected, in whole or in part, as
promptly as practical after receipt. The Purchaser agrees that subscriptions need not be accepted in the order subscriptions are
received by the Company. Upon rejection of this Agreement for any reason, all items received with this Agreement shall be returned
to the Purchaser without deduction for any fee, commission or expense and without accrued interest with respect to any money received,
and this Agreement shall be deemed to be null and void and of no further force or effect.

 

3.
Representations, Warranties and Covenants of the Purchaser. The Purchaser hereby represents, warrants to, and covenants
with the Company and the Placement Agent as follows:

 

(a)
The Shares (collectively, the “Securities”) offered in this Offering are not registered under the Securities
Act of 1933, as amended (the “Securities Act”), or any state securities laws. The Purchaser understands
that the Offering and sale of the Securities contemplated hereby is intended to be exempt from registration under the Securities
Act, by virtue of Section 4(a)(2) thereof and the provisions of Rule 506(b) of Regulation D promulgated thereunder, based, in
part, upon the representations, warranties and agreements of the Purchaser contained in this Agreement.

 

(b)
he Purchaser and the Purchaser’s attorney, accountant, purchaser representative and/or tax advisor, if any (collectively,
the “Advisors”), acknowledges that it has received the Offering Documents, either in hard copy or electronically,
and all other documents requested by the Purchaser, has carefully reviewed them and understands the information contained therein,
and the Purchaser and the Advisors, if any, prior to the execution of this Agreement, have had access to the same kind of information
as would be available in a registration statement filed by the Company under the Securities Act. Purchaser’s decision to
enter into this Agreement has been made based solely on the independent evaluation by the Purchaser and its Advisors, if any.

 

    	 	 	 

     

    

 

(c)
Neither the SEC nor any state securities commission or other regulatory body has approved the Shares, or passed upon or endorsed
the merits of the Offering or confirmed the accuracy or determined the adequacy of the Offering Documents. Any representation
to the contrary is a criminal offense. The Offering Documents have not been reviewed by any federal, state or other regulatory
authority. The Securities are subject to restrictions on transferability and resale and may not be transferred or resold except
as permitted under the Securities Act, and the applicable state securities laws, pursuant to registration or exemption therefrom.

 

(d)
All documents, records, and books pertaining to the investment in the Shares (including, without limitation, the Offering Documents)
have been made available for inspection by the Purchaser and its Advisors, if any.

 

(e)
The Purchaser and its Advisors, if any, have had a reasonable opportunity to ask questions of and receive answers from a person
or persons acting on behalf of the Company concerning the Offering of the Shares and the business, financial condition, and results
of operations of the Company, and all such questions have been answered by representatives of the Company to the full satisfaction
of the Purchaser and its Advisors, if any.

 

(f)
In evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representation or other information
(oral or written) other than as stated in the Offering Documents or as contained in documents so furnished to the Purchaser or
its Advisors, if any, by the Company.

 

(g)
The Purchaser is unaware of, is in no way relying on, and did not become aware of the Offering of the Shares directly or indirectly
through or as a result of, any form of general solicitation or general advertising including, without limitation, any press release,
article, notice, advertisement or other communication published in any newspaper, magazine or similar media or broadcast over
television, radio or the internet (including without limitation, internet “blogs,” bulletin boards, discussion groups
or social networking sites) in connection with the Offering and sale of the Shares and is not subscribing for the Shares and did
not become aware of the Offering of the Shares through or as a result of any seminar or meeting to which the Purchaser was invited
by, or any solicitation of a subscription by, a person not previously known to the Purchaser in connection with investments in
securities generally.

 

(h)
Other than R.W. Pressprich & Co. who is acting as placement agent (the “Placement Agent”) for the
Company in the Offering, and any broker-dealer and member of FINRA who the Placement Agent may have retained to offer and sell
Shares in this Offering, the Purchaser is not aware of any person and has been advised that no person, will receive from the Company
any compensation as a broker, finder, adviser or in any other capacity in connection with the purchase of the Shares.

 

(i)
The Purchaser, either alone or together with its Advisors, if any, has such knowledge and experience in financial, tax, and business
matters, and, in particular, investments in securities, so as to enable it to utilize the information made available to it in
connection with the Offering, to evaluate the merits and risks of an investment in the Shares and the Company and to make an informed
investment decision with respect thereto.

 

(j)
The Purchaser understands that the Company will review this Agreement and the Purchaser’s Confidential Purchaser Questionnaire
which is attached hereto as Exhibit A and incorporated herein by such reference and the Company is hereby given
authority by the Purchaser to call the Purchaser’s bank or place of employment or otherwise investigate or review the financial
standing of the Purchaser; and it is further agreed that the Company reserves the unrestricted right to reject or limit any subscription
and to close the offer at any time.

 

    	 	2	 

     

    

 

(k)
The Purchaser is not relying on the Company, the Placement Agent or any of their respective employees or agents with respect to
the legal, tax, economic and related considerations of an investment in the Shares, and the Purchaser has relied on the advice
of, or has consulted with, only its own Advisors, if any.

 

(l)
The Purchaser represents that the Shares are being purchased for the Purchaser’s own account, for investment purposes only
and not with a view for distribution or resale to others. The Purchaser agrees that the Purchaser will not sell or otherwise transfer
the Securities unless the Securities are registered under the Securities Act or unless in the opinion of counsel satisfactory
to the Company an exemption from such registration is available. The Purchaser understands that the Securities have not been registered
under the Securities Act by reason of a claimed exemption under the provisions of the Securities Act which depends, in part, upon
the Purchaser’s investment intention. In this connection, the Purchaser understands that it is the position of the SEC that
the statutory basis for such exemption would not be present if the Purchaser’s representation merely meant that the Purchaser’s
present intention was to hold such Shares for a short period, such as the capital gains period of tax statutes, for a deferred
sale or for any other fixed period. The Purchaser realizes that the SEC might regard a purchase with an intent inconsistent with
the Purchaser’s representation to the Company, and a sale or disposition thereof, as a deferred sale to which the exemption
is not available.

 

(m)
The purchase of the Shares represents a high risk capital investment and the Purchaser is able to afford an investment in a speculative
venture having the risks and objectives of the Company. The Purchaser must bear the substantial economic risks of the investment
in the Shares indefinitely because none of the Securities may be sold, hypothecated or otherwise disposed of unless subsequently
registered under the Securities Act and applicable state securities laws or an exemption from such registration is available.
Legends shall be placed on the Securities to the effect that they have not been registered under the Securities Act or applicable
state securities laws and appropriate notations thereof will be made in the Company’s books. Stop transfer instructions
will be placed with the transfer agent of the Securities.

 

(n)
The Purchaser has adequate means of providing for such Purchaser’s current financial needs and foreseeable contingencies
and has no need for liquidity of its investment in the Shares for an indefinite period of time.

 

(o)
The Purchaser satisfies any special suitability or other applicable requirements of his state of residence and/or the state in
which the transaction by which the Shares are purchased occurs.

 

(p)
The Purchaser is aware that an investment in the Shares involves a number of very significant risks. The Purchaser is aware of
the following additional risk factors:

 

Prospective
investors must undertake their own due diligence.

 

The
Offering Documents contain limited information regarding our company, our current and future business and operations, our management
and our financial condition. While we believe the information contained in the Offering Documents accurate, such document is not
meant to contain an exhaustive discussion regarding our company. We cannot guarantee a prospective investor that the abbreviated
nature of the Offering Documents will not omit to state a material fact which a prospective investor may believe to be an important
factor in determining if an investment in the Shares is appropriate for such investor. As a result, prospective investors are
required to undertake their own due diligence of our company, our current and proposed business and operations, our management
and our financial condition to verify the accuracy and completeness of the information we are providing in the Offering Documents.
This investment is suitable only for accredited investors who have the knowledge and experience to independently evaluate our
company, our business and prospects.

 

    	 	3	 

     

    

 

This
is a “best efforts” Offering and there are no assurances we will sell all of the Shares offered hereby.

 

This
is a “best efforts” offering which means there is no guarantee as to the minimum number of Shares we may sell in this
Offering. There are no assurances we will sell a sufficient number of Shares to accomplish our goals which are described in these
Offering Documents. If we sell less than all of the Shares offered hereby, we will have significantly less funds available to
us for general working capital and for the other purposes described herein.

 

Our
management has full discretion as to the use of proceeds from the Offering.

 

We
expect to use the net proceeds from this Offering for working capital, protein development, laboratory and testing equipment necessary
to support such development, regulatory and clinical expenses, and development work to extend the patent life of NELL-1, as well
as for other purposes not presently contemplated herein but which are related directly to growing our current business. As a result
of the foregoing, purchasers of the Shares offered hereby will be entrusting their funds to our management, upon whose judgment
and discretion the investors must depend, with only limited information concerning management’s specific intentions.

 

(q)
The Purchaser meets the requirements of at least one of the suitability standards for an “accredited investor” as
that term is defined in Regulation D under the Securities Act, and has truthfully and accurately completed the Purchaser’s
Confidential Purchaser Questionnaire contained herein.

 

(r)
The Purchaser: (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full power and authority
to execute and deliver this Agreement and all other related agreements or certificates and to carry out the provisions hereof
and thereof; (ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock company,
trust, unincorporated organization or other entity, such entity is duly organized, validly existing and in good standing under
the laws of the state of its organization, the consummation of the transactions contemplated hereby is authorized by, and will
not result in a violation of state law or its charter or other organizational documents, such entity has full power and authority
to execute and deliver this Agreement and all other related agreements or certificates and to carry out the provisions hereof
and thereof and to purchase and hold the Shares, the execution and delivery of this Agreement has been duly authorized by all
necessary action, this Agreement has been duly executed and delivered on behalf of such entity and is a legal, valid and binding
obligation of such entity; or (iii) if executing this Agreement in a representative or fiduciary capacity, represents that it
has full power and authority to execute and deliver this Agreement in such capacity and on behalf of the subscribing individual,
ward, partnership, trust, estate, corporation, or limited liability company or partnership, or other entity for whom the Purchaser
is executing this Agreement, and such individual, partnership, ward, trust, estate, corporation, or limited liability company
or partnership, or other entity has full right and power to perform pursuant to this Agreement and make an investment in the Company,
and represents that this Agreement constitutes a legal, valid and binding obligation of such entity. The execution and delivery
of this Agreement will not violate or be in conflict with any order, judgment, injunction, agreement or controlling document to
which the Purchaser is a party or by which it is bound.

 

(s)
Any information which the Purchaser has heretofore furnished or is furnishing herewith to the Company and/or the Placement Agent
is complete and accurate and may be relied upon by the Company and the Placement Agent in determining the availability of an exemption
from registration under Federal and state securities laws in connection with the Offering. The Purchaser further represents and
warrants that it will notify and supply corrective information to the Company and the Placement Agent immediately upon the occurrence
of any change therein occurring prior to the Company’s issuance of the Shares.

 

    	 	4	 

     

    

 

(t)
The Purchaser has significant prior investment experience, including investments in non-registered securities. The Purchaser has
a sufficient net worth to sustain a loss of its entire investment in the Company in the event such a loss should occur. The Purchaser’s
overall commitment to investments which are not readily marketable is not excessive in view of the Purchaser’s net worth
and financial circumstances and the purchase of the Shares will not cause such commitment to become excessive. The investment
is a suitable one for the Purchaser.

 

(u)
No oral or written representations have been made, or oral or written information furnished, to the Purchaser or its Advisors,
if any, in connection with the Offering which are in any way inconsistent with the information contained in the Offering Documents.

 

(v)
The Purchaser has relied only on the information contained in the Securities Filings.

 

(w)
The Purchaser understands and agrees that all certificates representing the Shares will contain the following restrictive legend:

 

THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“1933 ACT”), OR ANY STATE
SECURITIES LAWS AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED OR DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE 1933 ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL SATISFACTORY TO COUNSEL TO DB COWORKING
HOLDINGS CORP. THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS IS AVAILABLE.

 

(x)
The Purchaser should check the Office of Foreign Assets Control (“OFAC”) website at <http://www.treas.gov/ofac>
before making the following representations. The Purchaser represents that the amounts invested by it in the Company in the
Offering were not and are not directly or indirectly derived from activities that contravene federal, state or international laws
and regulations, including anti-money laundering laws and regulations. Federal regulations and Executive Orders administered by
OFAC prohibit, among other things, the engagement in transactions with, and the provision of services to, certain foreign countries,
territories, entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found
on the OFAC website at <http://www.treas.gov/ofac>. In addition, the programs administered by OFAC (the “OFAC
Programs”) prohibit dealing with individuals1 or entities in certain countries regardless of whether
such individuals or entities appear on the OFAC lists.

 

(y)
To the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a country, territory, individual or entity
named on an OFAC list, or a person or entity prohibited under the OFAC Programs. Please be advised that the Company may not accept
any amounts from a prospective investor if such prospective investor cannot make the representations set forth in the preceding
paragraph. The Purchaser agrees to promptly notify the Company and the Placement Agent should the Purchaser become aware of any
change in the information set forth in these representations. The Purchaser understands and acknowledges that, by law, the Company
may be obligated to “freeze the account” of the Purchaser, either by prohibiting additional subscriptions from the
Purchaser, declining any redemption requests and/or segregating the assets in the account in compliance with governmental regulations.
The Purchaser further acknowledges that the Company may, by written notice to the Purchaser, suspend the redemption rights, if
any, of the Purchaser if the Company reasonably deems it necessary to do so to comply with anti-money laundering regulations applicable
to the Company or any of the Company’s other service providers. These individuals include specially designated nationals,
specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs.

 

 

1
These individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject
to OFAC sanctions and embargo programs.

 

    	 	5	 

     

    

 

(z)
To the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a senior foreign political figure[2],
or any immediate family[3] member or close associate[4] of a senior foreign political figure, as such terms
are defined in the footnotes below.

 

(aa)
If the Purchaser is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Purchaser
receives deposits from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Purchaser
represents and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address,
in a country in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records
related to its banking activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign
Bank to conduct banking activities; and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that
does not have a physical presence in any country and that is not a regulated affiliate.

 

(bb)
(For ERISA plans only) The fiduciary of the ERISA plan represents that such fiduciary has been informed of and understands
the Purchaser’s investment objectives, policies and strategies, and that the decision to invest “plan assets”
(as such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require diversification of plan
assets and impose other fiduciary responsibilities. The Purchaser fiduciary or plan (a) is responsible for the decision to invest
in the Company; (b) is independent of the Company or any of its affiliates; (c) is qualified to make such investment decision;
and (d) in making such decision, the Purchaser fiduciary or plan has not relied primarily on any advice or recommendation of the
Company or any of its affiliates.

 

(cc)
The Purchaser: (i) if a natural person, represents on its behalf; or (ii) if a corporation, partnership, or limited liability
company or partnership, or association, joint stock corporation or other entity, represents on its behalf and the behalf of its
officers, directors and principal stockholders, connected with the Purchaser at the time of this Agreement, that it is not subject
to any “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualifying
Event”), except for a Disqualifying Event covered by Rule 506(d)(2) or (d)(3).

  

 

2
A “senior foreign political figure” is defined as a senior official in the executive, legislative, administrative,
military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political
party, or a senior executive of a foreign government owned corporation. In addition, a “senior foreign political figure”
includes any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political
figure.

 

3
“Immediate family” of a senior foreign political figure typically includes the figure’s parents, siblings,
spouse, children and in-laws.

 

4
A “close associate” of a senior foreign political figure is a person who is widely and publicly known to maintain
an unusually close relationship with the senior foreign political figure, and includes a person who is in a position to conduct
substantial domestic and international financial transactions on behalf of the senior foreign political figure.

 

    	 	6	 

     

    

 

The
foregoing representations and warranties are true and accurate as of the date hereof, shall be true and accurate as of the date
of delivery of this Agreement and accompanying documents to the Company and Placement Agent and shall survive such delivery. If,
in any respect, those representations and warranties shall not be true and accurate prior to delivery of the payment pursuant
to paragraph 1, the undersigned shall immediately give written notice to the Company and the Placement Agent specifying which
representations and warranties are not true and accurate and the reason therefor. In addition, the Purchaser agrees to notify
the Company and the Placement Agent immediately in writing if the Purchaser ceases to be an “accredited investor”
within the meaning of Rule 501(a) of Regulation D under the Securities Act. Until the Purchaser provides a notice described in
the preceding two sentences, the Company and the Placement Agent may rely on the representations, warranties, covenants and agreements
contained herein in connection with any matter related to the Company and/or the Placement Agent. Without limiting the generality
of the preceding sentence, the Company and the Placement Agent may assume that all such representations and warranties are correct
in all respects as of the date hereof and may rely on such representations and warranties in determining whether (i) the Purchaser
is suitable as a purchaser of Shares, (ii) Shares may be sold to the Purchaser or any other Purchaser without first registering
the Shares under the Securities Act or any other applicable securities laws, (iii) the conditions to the acceptance of subscriptions
for Shares have been satisfied, and (iv) the Purchaser meets the eligibility standards set by the Company.

 

4.
Representations, Warranties and Covenants of the Company. The Company hereby represents, warrants to and covenants
with the Purchaser as follows:

 

(a)
The Company is a corporation duly organized, validly existing and in good standing under the laws of the state of Delaware. The
Company is not in violation of any of the provisions of its certificate of incorporation, by-laws or other organizational or charter
documents, each as may be amended (the “Internal Documents”). The Company is qualified to transact business
as a foreign corporation and is in good standing under the laws of each jurisdiction where the location of its properties or the
conduct of its business makes such qualification necessary, except where the failure to be so qualified would not have a material
adverse effect on the business, assets, liabilities, results of operations, condition (financial or otherwise), properties or
prospects of the Company.

 

(b)
The Company has all power and authority to: (i) conduct its business as presently conducted and as proposed to be conducted as
described in the Offering Documents; (ii) enter into and perform its obligations under this Agreement; and (iii) issue, sell and
deliver the Shares. The execution and delivery of each of the Agreement and the issuance, sale and delivery of the Shares has
been duly authorized by all necessary corporate action. This Agreement has been duly executed and when delivered will constitute
upon due execution and delivery, will constitute, valid and binding obligations of the Company, enforceable against the Company
in accordance with its terms except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium
or other similar laws now or hereafter in effect relating to or affecting creditors’ rights generally, including the effect
of statutory and other laws regarding fraudulent conveyances and preferential transfers, and except that no representation is
made herein regarding the enforceability of the Company’s obligations to provide indemnification and contribution remedies
under the securities laws and subject to the limitations imposed by general equitable principles (regardless of whether such enforceability
is considered in a proceeding at law or in equity).

 

(c)
The Shares will be duly and validly issued, fully paid and non-assessable, and free from all taxes or liens with respect to the
issue thereof and shall not be subject to preemptive rights, rights of first refusal and/or other similar rights of stockholders
of the Company and/or any other person.

 

    	 	7	 

     

    

 

(d)
No action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the
Company or its property is pending or, to the best knowledge of the Company, threatened that (i) could reasonably be expected
to have a material adverse effect on the performance of this Agreement or the other Offering Documents by the Company or the consummation
of any of the transactions contemplated hereby or thereby, and/or (ii) could reasonably be expected to have a material adverse
effect on the Company’s operations.

 

(e)
The Company owns or leases all such properties as are necessary to the conduct of its operations as presently conducted.

 

(f)
The Company is not in (i) violation or default of any provision of its Internal Documents; (ii) default or material violation
of the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation,
condition, covenant or instrument to which it is a party or bound or to which its property is subject; and/or (iii) default or
material violation of any statute, law, rule, regulation, judgment, order or decree applicable to the Company of any court, regulatory
body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Company or any of its
properties, as applicable.

 

(g)
The Company has filed all U.S. federal, state and local tax returns that are required to be filed or has requested or will request
extensions thereof and has paid all taxes required to be paid by it and any other assessment, fine or penalty levied against the
Company, to the extent that any of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently
being contested in good faith.

 

(h)
Assuming the accuracy of the Purchaser’s representations and warranties set forth in this Agreement, no registration under
the Securities Act of the Shares is required for the offer and sale of the Shares to the Purchaser in the manner contemplated
herein and in the Offering Documents.

 

(i)
The Company has not engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under
the Securities Act) in connection with the offer or sale of any of the Shares.

 

(j)
Since the date of the Offering Documents, there has not been:

 

	 	(i)	any
    material adverse change in the financial condition, operations or business of the Company from that shown on the Company Financial
    Statements, or any material transaction or commitment effected or entered into by the Company outside of the ordinary course
    of business;
	 	 	 
	 	 (ii)	any
    issuance by the Company of any securities, other than grants of options under the Company’s stock option plan(s) made
    to its officers, directors and employees; or
	 	 	 
	 	(iii)
    	any
    incurrence of any material liability by the Company outside of the ordinary course of business.

 

(k)
The books of account, ledgers, order books, records and documents of the Company accurately and completely reflect all material
information relating to the business of the Company, the location and collection of its assets, and the nature of all transactions
giving rise to the obligations or accounts receivable of the Company.

 

    	 	8	 

     

    

 

(l)
The Company shall file a Form D with respect to the Shares as required under Regulation D. The Company shall legally qualify the
Shares for sale to the Purchasers in each Closing pursuant to this Offering Materials under applicable securities or “blue
sky” laws of the states of the United States (or obtain an exemption from such qualification), and shall pay all fees and
expenses of such counsel in connection therewith, including, but not limited to, all state filing fees and such counsel’s
legal fees and expenses.

 

(m)
Except for commissions which may be paid to the Placement Agent, the Company has taken no action which would give rise to any
claim by any person for brokerage commissions, transaction fees or similar payments relating to this Agreement or the transactions
contemplated hereby.

 

(n)
None of the information set forth in the Offering Documents contains any untrue statement of material fact or omits to state any
material fact necessary in order to make the statements made herein or therein, in light of the circumstances under which they
were made, not misleading.

 

5.
Indemnification. The Purchaser acknowledges that the Purchaser understands the meaning and legal consequences of
the representations, warranties and covenants in Section 3 hereof and that the Company and the Placement Agent have relied
upon such representations, warranties and covenants, and the Purchaser hereby agrees to indemnify and hold harmless the Company,
the Placement Agent and each of their respective officers, directors, controlling persons, agents and employees, from and against
any and all losses, damages or liabilities due to or arising out of a breach of any representation, warranty or covenant made
by the Purchaser herein. Notwithstanding the foregoing, however, no representation, warranty, covenant, acknowledgment or agreement
made herein by the Purchaser shall in any manner be deemed to constitute a waiver of any rights granted to the Purchaser under
Federal or state securities laws. All representations, warranties and covenants contained in this Agreement and the indemnification
contained in this Section 5 shall survive the acceptance of this subscription.

 

6.
Restrictions on Transfer. The Purchaser understands and agrees that the Securities shall not be sold, pledged, hypothecated
or otherwise transferred unless the Securities are registered under the Securities Act and applicable state securities laws or
are exempt therefrom.

 

7.
Irrevocability; Binding Effect. The Purchaser hereby acknowledges and agrees that the subscription hereunder is
irrevocable by the Purchaser, except as required by applicable law, and that this Agreement shall survive the death or disability
of the Purchaser and shall be binding upon and inure to the benefit of the parties and their heirs, executors, administrators,
successors, legal representatives, and permitted assigns. If the Purchaser is more than one person, the obligations of the Purchaser
hereunder shall be joint and several and the agreements, representations, warranties, and acknowledgments herein shall be deemed
to be made by and be binding upon each such person and such person’s heirs, executors, administrators, successors, legal
representatives, and permitted assigns.

 

8.
Investor Qualification. The Purchaser previously or simultaneously herewith has furnished a completed and executed
Confidential Purchaser Questionnaire, the information in which is true and correct in all respects and which is hereby incorporated
by reference herein.

 

9.
Modification. Neither this Agreement nor any provision hereof shall be waived, modified, changed, discharged or
terminated except by an instrument in writing signed by the party against whom any waiver, modification, change, discharge or
termination is sought.

 

10.
Notices. All notices, requests, consents and other communications hereunder shall be in writing and shall be deemed
to have been duly made when delivered, or mailed by registered or certified mail, return receipt requested:

 

    	 	9	 

     

    

 

(a)
If to the Purchaser, to the address set forth on the signature page of this Agreement, or at such other address as the Purchaser
may hereafter have advised the Company by written notification.

 

(b)
If to the Company, to the address set forth on the first page of this Agreement, or at such other address as the Company may hereafter
have advised the Purchaser by written notification.

 

11.
Survival of Representations and Warranties. Each party hereto covenants and agrees that the representations and
warranties of such party contained in this Agreement shall survive the Closing.

 

12.
Entire Agreement. This Agreement contains the entire agreement of the parties with respect to the matters set forth
herein and supersede all prior oral or written agreements and understandings, if any, relating to the subject matter hereof.

 

13.
Assignability. This Agreement is not transferable or assignable by the undersigned or any successor thereto.

 

14.
Registration Rights. One or more Purchasers (collectively, the “Demand Holder”) holding not less than
500,000 Shares, may make a written request, which request will specify the aggregate number of Shares to be registered and will
also specify the intended methods of disposition thereof (the “Request Notice”) to the Company for registration with
the SEC under and in accordance with the provisions of the Securities Act of all or part of the Shares then owned by the Demand
Holder (a “Demand Registration”). Upon any request for a Demand Registration, the Company will use commercially reasonable
efforts to effect the prompt registration under the Securities Act of the Shares which the Company has been so requested to register
by the Demand Holder as contained in the Request Notice, all to the extent required to permit the disposition of the Shares so
to be registered in accordance with the intended method or methods of disposition of each seller of such Shares. The Company will
not be required to effect more than one Demand Registration. It shall be a condition precedent to the obligations of the Company
to take any action that Purchasers requesting inclusion in any registration shall furnish to the Company such information regarding
them, the Shares held by them, the intended method of disposition of such Shares and other matters as the Company shall reasonably
request and as shall be required in connection with the action to be taken by the Company. The obligations hereunder shall expire
at such time as the Shares may be sold to the pubic without registration without regard to the volume and manner requirements
under Rule 144.

 

15.
Governing Law; Waiver Of Jury Trial, Etc. This Agreement shall be governed by and construed solely and exclusively
under and pursuant to the laws of the State of Delaware as applied to agreements among Delaware residents entered into and to
be performed entirely within Delaware. THE PARTIES HERETO AGREE TO WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM
OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY DOCUMENT OR AGREEMENT CONTEMPLATED HEREBY. THE PARTY PREVAILING
THEREIN SHALL BE ENTITLED TO PAYMENT FROM THE OTHER PARTY HERETO OF ALL OF ITS REASONABLE COUNSEL FEES AND DISBURSEMENTS.

 

16.
Further Assurances. Each party hereto shall do and perform or cause to be done and performed all such further acts
and shall execute and deliver all such other agreements, certificates, instruments and documents as any other party hereto reasonably
may request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

    	 	10	 

     

    

 

17.
Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be
an original, and all of which shall constitute one and the same document. In the event that any signature (including a financing
signature page) is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature
shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile or “pdf” signature page were an original thereof.

 

18.
Use of Pronouns and Defined Terms. All pronouns and any variations thereof used herein shall be deemed to refer
to the masculine, feminine, neuter, singular or plural as the identity of the person or persons referred to may require. All terms
not otherwise defined herein shall have the same meaning as in the Offering Documents.

 

19.
Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as
to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining
provisions hereof but shall be interpreted as if it were written so as to be enforceable to the maximum extent permitted by applicable
law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision
in any other jurisdiction. To the extent permitted by applicable law, the parties hereby waive any provision of law which renders
any provision hereof prohibited or unenforceable in any respect.

 

20.
Most Favored Nations. From the date hereof until such time as the Offering is terminated, in the event the Company
issues or sells any shares of Common Stock or securities directly or indirectly convertible into or exercisable for Common Stock
(“Common Stock Equivalents”) or amends the Offering Documents relating to any sale or issuance of Common Stock or
Common Stock Equivalents, if the terms and conditions thereunder are more favorable to such investors as the terms and conditions
granted under the Offering Documents, the Offering Documents shall be deemed automatically amended so as to give the Purchaser
the benefit of such more favorable terms or conditions and the Company shall provide to Purchaser the benefits thereof including,
if applicable, issuing additional Shares or providing or modifying the Common Stock Equivalents. The Company shall provide Purchaser
with all executed transaction documents relating to any such sale or issue of Common Stock or Common Stock Equivalents.

 

[SIGNATURE
PAGE TO FOLLOW]

 

    	 	11	 

     

    

 

IN
WITNESS WHEREOF, the undersigned has executed this Agreement on the date his signature has been subscribed and sworn to below.

 

	No.
    of Shares: _____________________	 	Amount
    of Subscription: $_________________
	 	 	 
	The
    Shares are to be issued in 	 	____________________________________________
	(check
    one box):	 	Print
    Name of Investor
	 	 	 
	[  ]
    individual name	 	____________________________________________
	 	 	Print
    Name of Joint Investor (if applicable)
	[  ]
    joint tenants with rights of survivorship	 	 
	 	 	____________________________________________
	[  ]
    tenants in entirety	 	Signature
    of Investor
	 	 	 
	[  ]
    corporation (an officer must sign)	 	____________________________________________
	 	 	Signature
    of Joint Investor
	[  ]
        partnership (all general partners must sign)

         

        [  ]
        trust

         

        [  ]
        limited liability company
	 	 
	 	 	___________________________________
	 	 	Print
    Name of Trust, Corporation, Partnership, LLC or other Institutional 
	email
    address: _______________________	 	Investor
	 	 	 
	fax
    number: _________________________	 	 
	 	 	By:__________________________________________
	Subscriber(s)
    address:	 	 
	________________________________	 	Title:_________________________________________
	________________________________	 	 
	 	 	_____________________________________________
	Taxpayer
    ID No.: _____________________	 	Name
    of natural person with voting and dispositive control over the Shares being subscribed for

 

Accepted
as of this day of , 2017

 

BONE
BIOLOGICS CORPORATION

 

By:
____________________________________

Stephen
LaNeve, Chief Executive Officer

 

    	 	12	 

     

    

 

EXHIBIT
A

 

CONFIDENTIAL
PURCHASER QUESTIONNAIRE

 

PART
I: INFORMATION TO BE PROVIDED BY ALL INVESTORS.

 

	A.	 	Name
    of Purchaser: _____________________________________________________
	 	 	 
	B.	 	Accreditation.
    Check all boxes which correctly describe you:
	 	 	 
	[  ]	 	You
    are a natural person whose individual net worth, or joint net worth with your spouse, at the time of purchase, exceeds $1,000,000.
    For the purposes of calculating net worth under this paragraph:

 

	 	●	your
    primary residence cannot be included as an asset;
	 	 	 
	 	●	indebtedness
    that is secured by your primary residence, up to the estimated fair market value of the primary residence at the time of the
    sale of securities, is not included as a liability except that if the amount of such indebtedness outstanding at the
    time of the sale of securities exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition
    of the primary residence, the amount of such excess is included as a liability; and
	 	 	 
	 	●	indebtedness
    that is secured by your primary residence in excess of the estimated fair value of the primary residence at the time of the
    sale of securities is included as a liability.

 

	[  ]	You
    are a natural person who had an individual income in excess of $200,000 in each of the two most recent years or a joint income
    with your spouse in excess of $300,000 in each of those years and have a reasonable expectation of reaching the same income
    level during the current year.
	 	 
	[  ]	You
    are a director of the Company.
	 	 
	[  ]	You
    have total assets in excess of $5,000,000 and were not formed for the specific purpose of acquiring the securities offered
    by the Company and are any of the following: a corporation, a partnership, a Massachusetts or similar business trust, or an
    organization described in Section 501(c)(3) of the Internal Revenue Code.
	 	 
	[  ]	You
    are a bank or savings and loan association or other institution acting in your individual or fiduciary capacity.
	 	 
	[  ]	You
    are a broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934.
	 	 
	[  ]	You
    are an insurance company.
	 	 
	[  ]	You
    are an investment company or business development company under the Investment Company Act of 1940.
	 	 
	[  ]	You
    are a private business development company under the Investment Advisers Act of 1940.

 

    	 	13	 

     

    

 

	[  ]	You
    are a Small Business Investment Company licensed by the U.S. Small Business Administration under 301(c) or (d) of the Small
    Business Investment Act of 1958.

 

	[  ]	You
    are a trust, not formed for the specific purpose of acquiring the Shares offered by the Company, with total assets in excess
    of $5,000,000 and whose purchase is directed by a sophisticated person.

 

	[  ]	You
    are an employee benefit plan whose investment decision is being made by a plan fiduciary, which is either a bank, savings
    and loan association, insurance company or registered investment adviser, or an employee benefit plan whose total assets are
    in excess of $5,000,000 or a self-directed employee benefit plan whose investment decisions are made solely by persons that
    are “accredited investors” (i.e., they meet any of the standards listed above).

 

	[  ]	You
    are an entity as to which all of the equity owners (or, in the case of a trust, all of the income beneficiaries) are “accredited
    investors” (i.e., they must meet one or more of the standards listed above).

 

	[  ]	None
    of the above.

 

	C.	Provide
    Answers to the Following Questions:

 

	1.	Are
    you directly or indirectly an affiliate or associate of any member firm of the Financial Industry Regulatory
    Authority, Inc. (“FINRA”)?

 

	 	[  ]	Yes	 	[  ]	No

 

	 	An
    “affiliate” of a specified person is a person that directly or indirectly through one or more intermediaries,
    controls or is controlled by, or is under common control with the specified person.
	 	 
	 	The
    term “associate” means (1) any corporation or organization (other than the Company or any subsidiary) or which
    you are an officer or partner, or of which you are, directly or indirectly, the owner beneficially of 10% or more of any class
    or equity securities, (2) any trust or other estate in which you have a substantial beneficial interest or as to which you
    serve as trustee or in a similar fiduciary capacity, or (3) any relative or spouse, who has the same home as such person or
    who is a director or officer of the Company of any of its subsidiaries.
	 	 
	 	If
    yes, please describe your affiliation or association:

 

	2.	Have
    you made any subordinated loans to any member of FINRA?

 

	 	[  ]	Yes	 	[  ]	No

 

	 	If
    yes, please set forth the details of the loan(s) including the original amount(s), date(s), interest rate(s), other material
    terms, and amount(s) outstanding as of the date hereof:

 

	3.	Are
    you subject to any “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities
    Act (a “Disqualifying Event”)? For the purposes of this question, if you are not a natural person(s) and the subscription
    is being made by a corporation, partnership, or limited liability company or partnership, or association, joint stock corporation
    or any other entity, “you” means all officers, directors and 5% or greater shareholders of the entity subscriber.
    Prior to responding to this question, please carefully review Annex 1 to this Confidential Purchaser Questionnaire which
    contains the full text of these rules.

 

	 	[  ]	Yes	 	[  ]	No

 

    	 	14	 

     

    

 

If
your answer is “yes,” please provide the complete details regarding such action(s) and attach copies of all relevant
documents.

 

4.
Are you subject to any pending action which if determined in a manner adverse to you could result in a Disqualifying Event? For
the purposes of this question, if you are not a natural person(s) and the subscription is being made by a corporation, partnership,
or limited liability company or partnership, or association, joint stock corporation or any other entity, “you” means
all officers, directors and 5% or greater shareholders of the entity subscriber. Prior to responding to this question, please
carefully review Annex 1 to this Confidential Purchaser Questionnaire which contains the full text of these rules.

 

	 	[  ]	Yes	 	[  ]	No

 

If
your answer is “yes,” please provide the complete details regarding such action(s) and attach copies of all relevant
documents.

 

    	 	15	 

     

    

 

PART
II: INFORMATION TO BE PROVIDED BY INDIVIDUAL INVESTORS:

 

Identify
the state in which you maintain your principal residence: ___________________________

 

Occupation:
___________________________________________________________________

 

Employer:
_____________________________________________________________________

 

If
self-employed, provide the following information:

 

Name
of business: ______________________________________________________________

 

Length
of time engaged in current business: _______ years.

 

The
current value of my liquid assets (cash, marketable securities, cash surrender value of my life insurance and other items easily
convertible into cash) is sufficient to provide for my current needs and possible personal contingencies:

 

	 	[  ]	Yes	 	[  ]	No

 

Education:

 

	Year	 	School	 	Field
    of Study	 	Degree	 	Date
    Conferred	 

	 	 
		 

 

Please
indicate the frequency of your investment in marketable securities, i.e., those where prices are quoted regularly on exchange
or in the over-the-counter market:

 

	 	[  ]	often	 	[  ]	occasionally	 	[  ]	seldom	 	[  ]	never

 

Do
you consider yourself to be an experienced and sophisticated investor?

 

	 	[  ]	Yes	 	[  ]	No

 

Do
you alone, or with your Purchaser Representative, have such knowledge and experience in financial and business matters that you
are capable of evaluating the risks and merits of this investment and feel that you can afford a loss of your entire investment
in the Company?

 

	 	[  ]	Yes	 	[  ]	No

 

    	 	16	 

     

    

 

PART
III: INFORMATION TO BE PROVIDED BY PURCHASERS OTHER THAN INDIVIDUALS

 

Identify
type of entity (corporation, trust, limited liability company, partnership or other entity):

 

		 

 

Identify
jurisdiction under the laws of which the entity is organized: ____________________

 

Identify
the date the entity was organized: _______________________________________

 

Identify
jurisdiction where the entity’s principal place of business is located:_____________

 

Describe
principal business conducted: _________________________________________

 

(You
may be asked to furnish a copy of a properly certified company resolution or organizational documents authorizing the purchaser
to make an investment of this type).

 

    	 	17	 

     

    

 

PART
IV: SIGNATURE

 

The
undersigned hereby represents and warrants that all of its answers to this Purchaser Questionnaire are true as of the date of
its execution of the Agreement pursuant to which it subscribed for the Shares.

 

	 	 	 
	Name
    of Purchaser (please print)	 	Name
    of Co-Purchaser (please print)
	 	 	 
	 	 	 
	Signature
    of Purchaser (Entities, please	 	Signature
    of Co-Purchaser
	provide
    signature of Purchaser’s duly	 	 
	authorized
    signatory.)	 	 

 

	 	 	 
	Name
    of Signatory (entities only)(please print)	 	 
	 	 	 
	 	 	 
	Title
    of Signatory (entities only)(please print)	 	 
	 	 	 
	Date:
    _______________________	 	 

 

    	 	18	 

     

    

 

Annex
1

 

“Bad
Actor” Disqualification

Rules
506(d)(1) and (2) of the Securities Act of 1933

 

(d)
“Bad Actor” disqualification. (1) No exemption under this section shall be available for a sale of securities
if the issuer; any predecessor of the issuer; any affiliated issuer; any director, executive officer, other officer participating
in the Offering, general partner or managing member of the issuer; any beneficial owner of 20% or more of the issuer’s outstanding
voting equity securities, calculated on the basis of voting power; any promoter connected with the issuer in any capacity at the
time of such sale; any investment manager of an issuer that is a pooled investment fund; any person that has been or will be paid
(directly or indirectly) remuneration for solicitation of purchasers in connection with such sale of securities; any general partner
or managing member of any such investment manager or solicitor; or any director, executive officer or other officer participating
in the Offering of any such investment manager or solicitor or general partner or managing member of such investment manager or
solicitor:

 

(i)
Has been convicted, within ten years before such sale (or five years, in the case of issuers, their predecessors and affiliated
issuers), of any felony or misdemeanor:

 

	 	(A)	In
    connection with the purchase or sale of any security;
	 	 	 
	 	(B)	Involving
    the making of any false filing with the Commission; or
	 	 	 
	 	(C)	Arising
    out of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer, investment adviser or paid
    solicitor of purchasers of securities;

 

(ii)
Is subject to any order, judgment or decree of any court of competent jurisdiction, entered within five years before such sale,
that, at the time of such sale, restrains or enjoins such person from engaging or continuing to engage in any conduct or practice:

 

	 	(A)	In
    connection with the purchase or sale of any security;
	 	 	 
	 	(B)	Involving
    the making of any false filing with the Commission; or
	 	 	 
	 	(C)	Arising
    out of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer, investment adviser or paid
    solicitor of purchasers of securities;

 

(iii)
Is subject to a final order of a state securities commission (or an agency or officer of a state performing like functions); a
state authority that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an
agency or officer of a state performing like functions); an appropriate federal banking agency; the U.S. Commodity Futures Trading
Commission; or the National Credit Union Administration that:

 

(A)
At the time of such sale, bars the person from:

 

	 	(1)	Association
    with an entity regulated by such commission, authority, agency, or officer;
	 	 	 
	 	(2)	Engaging
    in the business of securities, insurance or banking; or
	 	 	 
	 	(3)	Engaging
    in savings association or credit union activities; or

 

    	 	19	 

     

    

 

(B)
Constitutes a final order based on a violation of any law or regulation that prohibits fraudulent, manipulative, or deceptive
conduct entered within ten years before such sale;

 

(iv)
Is subject to an order of the Commission entered pursuant to section 15(b) or 15B(c) of the Securities Exchange Act of 1934 (15
U.S.C. 78 o (b) or 78 o -4(c)) or section 203(e) or (f) of the Investment Advisers Act of 1940 (15 U.S.C. 80b-3(e)
or (f)) that, at the time of such sale:

 

	 	(A)	Suspends
    or revokes such person’s registration as a broker, dealer, municipal securities dealer or investment adviser;
	 	 	 
	 	(B)	Places
    limitations on the activities, functions or operations of such person; or
	 	 	 
	 	(C)	Bars
    such person from being associated with any entity or from participating in the Offering of any penny stock;

 

(v)
Is subject to any order of the Commission entered within five years before such sale that, at the time of such sale, orders the
person to cease and desist from committing or causing a violation or future violation of:

 

	 	(A)	Any
    scienter-based anti-fraud provision of the federal securities laws, including without limitation section 17(a)(1) of the Securities
    Act of 1933 (15 U.S.C. 77q(a)(1)), section 10(b) of the Securities Exchange Act of 1934 (15 U.S.C. 78j(b)) and 17 CFR 240.10b-5,
    section 15(c)(1) of the Securities Exchange Act of 1934 (15 U.S.C. 78 o (c)(1)) and section 206(1) of the Investment
    Advisers Act of 1940 (15 U.S.C. 80b-6(1)), or any other rule or regulation thereunder; or
	 	 	 
	 	(B)	Section
    5 of the Securities Act of 1933 (15 U.S.C. 77e).

 

(vi)
Is suspended or expelled from membership in, or suspended or barred from association with a member of, a registered national securities
exchange or a registered national or affiliated securities association for any act or omission to act constituting conduct inconsistent
with just and equitable principles of trade;

 

(vii)
Has filed (as a registrant or issuer), or was or was named as an underwriter in, any registration statement or Regulation A offering
statement filed with the Commission that, within five years before such sale, was the subject of a refusal order, stop order,
or order suspending the Regulation A exemption, or is, at the time of such sale, the subject of an investigation or proceeding
to determine whether a stop order or suspension order should be issued; or

 

(viii)
Is subject to a United States Postal Service false representation order entered within five years before such sale, or is, at
the time of such sale, subject to a temporary restraining order or preliminary injunction with respect to conduct alleged by the
United States Postal Service to constitute a scheme or device for obtaining money or property through the mail by means of false
representations.

 

(2)
Paragraph (d)(1) of this section shall not apply:

 

(i)
With respect to any conviction, order, judgment, decree, suspension, expulsion or bar that occurred or was issued before September
23, 2013;

 

(ii)
Upon a showing of good cause and without prejudice to any other action by the Commission, if the Commission determines that it
is not necessary under the circumstances that an exemption be denied;

 

    	 	20	 

     

    

 

(iii)
If, before the relevant sale, the court or regulatory authority that entered the relevant order, judgment or decree advises in
writing (whether contained in the relevant judgment, order or decree or separately to the Commission or its staff) that disqualification
under paragraph (d)(1) of this section should not arise as a consequence of such order, judgment or decree; or

 

(iv)
If the issuer establishes that it did not know and, in the exercise of reasonable care, could not have known that a disqualification
existed under paragraph (d)(1) of this section.

 

(3)
For purposes of paragraph (d)(1) of this section, events relating to any affiliated issuer that occurred before the affiliation
arose will be not considered disqualifying if the affiliated entity is not:

 

(i)
In control of the issuer; or

 

(ii)
Under common control with the issuer by a third party that was in control of the affiliated entity at the time of such events.

 

    	 	21EX-10.2

 Exhibit 10.2 

AMENDMENT 
 TO SALE AND
SERVICING AGREEMENTS 
 This AMENDMENT TO SALE AND SERVICING AGREEMENTS, dated as of March 27, 2018 (this
“Amendment”), is by and between NISSAN AUTO RECEIVABLES CORPORATION II, a Delaware corporation (the “Seller”) and NISSAN MOTOR ACCEPTANCE CORPORATION (“NMAC”), a California corporation, as Servicer
(in such capacity, the “Servicer,” and together with the Seller, the “Parties”). 
 RECITALS: 

WHEREAS, separate and discrete Delaware statutory trust issuers (each, an “Issuer,” collectively, the
“Issuers”), certain indenture trustees (each as identified on Schedule A to this Amendment, an “Indenture Trustee”), the Seller, the Servicer and NMAC, in its individual capacity, have entered into Sale and
Servicing Agreements for each of the transactions listed on Schedule A to this Amendment (collectively the “Sale and Servicing Agreements”); 

WHEREAS, the Parties desire to amend Section 5.02(a) of each of the Sale and Servicing Agreements to modify the requirements of
the Monthly Remittance Condition (as such term is defined therein); and 
 WHEREAS, the Parties desire to implement such amendments
as of the Effective Date (as defined below) in accordance with the terms and conditions set forth below pursuant to Section 10.01(a) of each of the Sale and Servicing Agreements. 

NOW, THEREFORE, in consideration of the mutual agreements herein contained and other good and valuable consideration, receipt of which
is acknowledged, the Parties hereto agree as follows: 
 ARTICLE I 

RECITALS AND DEFINITIONS 

Section 1.1 Definitions. Capitalized terms used and not defined herein have the respective meanings assigned such
terms in the applicable Sale and Servicing Agreement. 
 ARTICLE II 

AMENDMENTS 

Section 2.1 Amendments to Group A Sale and Servicing Agreements. As of the Effective Date, the third sentence of
Section 5.02(a) of each Sale and Servicing Agreement for a Group A transaction (as identified in Schedule A) is hereby amended to replace the reference to “F1” therein with “F2”. 

Section 2.2 Amendments to Group B Sale and Servicing Agreements. As of the Effective Date, the second sentence of
Section 5.02(a) of each Sale and Servicing Agreement for a Group B transaction (as identified in Schedule A) is hereby amended to replace the reference to “F1” therein with “F2”. 

  

					
	 	 	 	 	 Amendment to

Sale and Servicing Agreements

 Section 2.3 Amendment to Group C Sale and Servicing Agreement. As of the
Effective Date, the second sentence of Section 5.02(a) of the Sale and Servicing Agreement for the Group C transaction (as identified in Schedule A) is hereby amended and restated in full to read as follows: 

“The “Monthly Remittance Condition” shall be deemed to be satisfied if (i) NMAC is the Servicer and
(ii) NMAC’s short-term unsecured debt obligations are rated at least “P-1” by Moody’s and at least “F2” by Fitch (so long as Moody’s and Fitch are Rating
Agencies).” 
 ARTICLE III 

EFFECTIVE DATE 

Section 3.1 Effective Date. Upon satisfaction of the following conditions this Amendment shall become effective
immediately (such date, the “Effective Date”) without further action by any Party: 
 (a) receipt by the Servicer of an
executed counterpart of this Amendment from each Party hereto; 
 (b) satisfaction of the Rating Agency Condition with respect to this
Amendment in accordance with Section 10.01(a)(ii) of each Sale and Servicing Agreement; and 
 (c) receipt by the Owner Trustee and
each Indenture Trustee of an Opinion of Counsel, as required pursuant to Section 10.01(d) of each Sale and Servicing Agreement, stating that the execution of such amendment is authorized or permitted by such Sale and Servicing Agreements. 

ARTICLE IV 

MISCELLANEOUS 

Section 4.1 Sale and Servicing Agreements Unaffected. Except as modified herein, the Parties acknowledge that the
provisions of each of the Sale and Servicing Agreements remain in full force and effect and are hereby ratified and confirmed by the Parties hereto. After the Effective Date all references in the applicable Basic Documents to a Sale and Servicing
Agreement shall mean such Sale and Servicing Agreement as modified hereby. 
 Section 4.2 Governing Law. This
Amendment shall be construed in accordance with the laws of the State of New York, without reference to its conflict of law provisions (other than Section 5-1401 of the General Obligations Law of the
State of New York), and the obligations, rights and remedies of the Parties hereunder shall be determined in accordance with such laws. 

  

					
	 	 	2	 	 Amendment to

Sale and Servicing Agreements

 Section 4.3 Captions. The various captions in this Amendment are
included for convenience only and shall not affect the meaning or interpretation of any provision of this Amendment or any provision hereof. 

Section 4.4 Severability. Whenever possible, each provision of this Amendment shall be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of this Amendment shall be prohibited by or invalid under the laws of any applicable jurisdiction, such provision, as to jurisdiction, shall be ineffective to the extent of such
prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Amendment as to such jurisdiction or any other jurisdiction. 

Section 4.5 Binding Effect. This Amendment shall be binding upon and inure to the benefit of the parties hereto and
their respective successors and assigns. 
 Section 4.6 Counterparts. This Amendment may be executed in any number
of counterparts and by the parties hereto on separate signature pages, each such executed counterpart constituting an original but all together only one Amendment. 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered as of the date first above written. 

 

			
	NISSAN AUTO RECEIVABLES CORPORATION II, as Seller
		
	By:	 	 /s/ Riley A. McAndrews

	Name:	 	Riley A. McAndrews
	Title: 	 	Assistant Treasurer

 
			
	
	NISSAN MOTOR ACCEPTANCE CORPORATION, Servicer
		
	By:	 	 /s/ Riley A. McAndrews

	Name:	 	Riley A. McAndrews
	Title: 	 	Assistant Treasurer

  

					
	 	 	3	 	 Amendment to

Sale and Servicing Agreements

 SCHEDULE A 
  

 

	 	

					
	Group A:	 		 	
			
		 	1.	 	Nissan Auto Receivables Owner Trust Series 2013-C
		 		 	    i. Indenture Trustee: U.S. Bank National Association
			
		 	2.	 	 Nissan Auto Receivables Owner Trust Series 2014-A

		 		 	    i. Indenture Trustee: Citibank, N.A.
			
		 	3.	 	Nissan Auto Receivables Owner Trust Series 2014-B
		 		 	    i. Indenture Trustee: Wells Fargo Bank, National Association
			
		 	4.	 	 Nissan Auto Receivables Owner Trust Series 2015-A

		 		 	    i. Indenture Trustee: Wells Fargo Bank, National Association
			
		 	5.	 	Nissan Auto Receivables Owner Trust Series 2015-B
		 		 	    i. Indenture Trustee: U.S. Bank National Association
			
		 	6.	 	Nissan Auto Receivables Owner Trust Series 2015-C
		 		 	    i. Indenture Trustee: U.S. Bank National Association
			
	Group B:	 		 	
			
		 	7.
	 	 Nissan Auto Receivables Owner Trust Series 2016-A

		 		 	     i. Indenture Trustee: U.S. Bank National Association

			
		 	8.	 	Nissan Auto Receivables Owner Trust Series 2016-B
		 		 	    i. Indenture Trustee: U.S. Bank National Association
			
		 	9.
	 	 Nissan Auto Receivables Owner Trust Series 2016-C

		 		 	     i. Indenture Trustee: U.S. Bank National Association

			
		 	10.	 	Nissan Auto Receivables Owner Trust Series 2017-A
		 		 	    i. Indenture Trustee: U.S. Bank National Association
			
		 	11.	 	Nissan Auto Receivables Owner Trust Series 2017-B
		 		 	    i. Indenture Trustee: U.S. Bank National Association
			
	Group C:	 		 	
			
		 	12.	 	Nissan Auto Receivables Owner Trust Series 2017-C
		 		 	    i. Indenture Trustee: U.S. Bank National Association

  

					
		 	4	 	 Amendment to

Sale and Servicing Agreements

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}]]